NYBC Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 5

Professionals

  • Investments
  • 24

  • Portfolio
  • 14

  • Exits
  • 4

Exits

NYBC Ventures General Information

Company Description

Founded in 2022, NYBC Ventures is the corporate venture capital arm of New York Blood Center, based in Boston, Massachusetts. The firm prefers to invest in early-stage companies operating in the cell therapy, transfusion medicine, benign hematology, and infectious disease sectors, of which emerging technologies, including in-vivo cell therapy, gene editing, iPSC, and regenerative medicine, are of interest.

Business Details

Year Founded
2022
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Corporate Office
  • 420 Boylston Street
  • Suite 501
  • Boston, MA 02116
  • United States

NYBC Ventures Investments (24)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Star Therapeutics 23-Oct-2026 Later Stage VC Biotechnology Generating Revenue
City Therapeutics 04-Jun-2026 Drug Discovery Generating Revenue/Not Profitable
Vitestro 02-Mar-2026 Diagnostic Equipment Generating Revenue
Lightning Biotherapeutics 01-Mar-2026 Biotechnology Stealth
TTP 09-Jan-2026 Consulting Services (B2B) Generating Revenue
Veralox Therapeutics 23-Sep-2025 Drug Discovery Generating Revenue
Star Therapeutics 22-Sep-2025 Biotechnology Generating Revenue
AvenCell 11-Sep-2025 Drug Discovery Clinical Trials - Phase 2
Akadeum Life Sciences 25-Apr-2025 Later Stage VC Discovery Tools (Healthcare) Generating Revenue
Immusoft 15-Mar-2025 Later Stage VC Drug Discovery Clinical Trials - Phase 1
You’re viewing 10 of 24 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NYBC Ventures Exits (4)

Company Name Exit Date Exit Type Exit Size
City Therapeutics 15-Oct-2026 IPO
Vega Therapeutics 06-Jul-2026
Thymmune 02-Jul-2026 Merger/Acquisition
Veralox Therapeutics 01-Jan-2026 Secondary Transaction - Private
To view NYBC Ventures’s complete exits history, request access »

NYBC Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

NYBC Ventures Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Blood Bank of Delmarva Newark, DE 1954

NYBC Ventures FAQs

  • What is NYBC Ventures?

    Founded in 2022, NYBC Ventures is the corporate venture capital arm of New York Blood Center, based in Boston, Massachusetts.

  • When was NYBC Ventures founded?

    NYBC Ventures was founded in 2022.

  • Where is NYBC Ventures headquartered?

    NYBC Ventures is headquartered in Boston, MA.

  • What is NYBC Ventures's total asset value?

    NYBC Ventures has around in total assets under management.

  • How many investments has NYBC Ventures made?

    NYBC Ventures has made 24 investments.

  • What has NYBC Ventures invested in?

    NYBC Ventures has made numerous investments in companies like Star Therapeutics, City Therapeutics, and Vitestro within the Biotechnology, Drug Discovery, and Diagnostic Equipment industries.

  • What has NYBC Ventures invested in recently?

    NYBC Ventures's latest investment was on 23-Oct-2026 in Star Therapeutics, a company within the Biotechnology industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process